Chris Tomassian, MD

home / authors / chris-tomassian-md

Chris Tomassian, MD, is a board-certified dermatologist and founder of The Dermatology Collective.

Articles

Social Media “Hacks”: DIY Sunscreen, Slugging, and More With Chris Tomassian, MD

Social Media “Hacks”: DIY Sunscreen, Slugging, and More With Chris Tomassian, MD

Maddi Hebebrand, MC, Associate Editor;Chris Tomassian, MD

March 17th 2025

Tomassian noted unrealistic beauty standards fueled by social media filters and edited images have led to distorted expectations.

Blending Clinical Practice and Social Media with Chris Tomassian, MD

Blending Clinical Practice and Social Media with Chris Tomassian, MD

Maddi Hebebrand, MC, Associate Editor;Chris Tomassian, MD

March 14th 2025

By staying authentic and leveraging real patient experiences, Tomassian ensures his content remains valuable and trustworthy.

Latest Updated Articles

2 KOLs are featured in this series.

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

Shawn Kwatra, MD, Endowed as Dr. Joseph Warren Burnett Professor of Dermatology at the University of Maryland School of Medicine

Published: April 16th 2025 | Updated: April 30th 2025

Shawn Kwatra, MD, Endowed as Dr. Joseph Warren Burnett Professor of Dermatology at the University of Maryland School of Medicine

SLIDESHOW: 2025 Pre-AAD Meetings

Published: March 4th 2025 | Updated: April 30th 2025

SLIDESHOW: 2025 Pre-AAD Meetings

Addressing the Challenges of Pigmentary Disorders in Women Across the Fitzpatrick Skin Spectrum

Published: March 19th 2025 | Updated: April 30th 2025

Addressing the Challenges of Pigmentary Disorders in Women Across the Fitzpatrick Skin Spectrum

FDA Approves First Gene Therapy for RDEB

Published: April 29th 2025 | Updated: April 30th 2025

FDA Approves First Gene Therapy for RDEB

POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?

Published: November 17th 2023 | Updated: April 30th 2025

POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?

Recent Content

Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use

Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use

Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics

Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics

Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata

Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata

JAKi and IL-4/-13i Show Similar Safety Profiles in AD

JAKi and IL-4/-13i Show Similar Safety Profiles in AD

View More Recent Content

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.